View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. News
September 17, 2021updated 01 Nov 2021 8:52am

Thermo Fisher Scientific launches new Covid-19 test kit

The new TaqPath Covid-19 RNase P 2.0 assay kit uses an RNase P control to ensure sample quality, integrity and extraction.

Thermo Fisher Scientific has launched the newly designed CE-IVD marked TaqPath Covid-19 RNase P 2.0 assay kit.

Free Report
img

Build resilience in the face of COVID-19 disruption

COVID-19 has already affected our lives forever. The way we work, shop, eat, seek medical advice, and socialize will all be different in the future. Quite how different remains to be seen, but all industries must plan for multiple eventualities. Are you interested in actionable insights on the business challenges induced by the pandemic? GlobalData's cross-sector report analyzes the significance of this major disruptive theme across industry verticals. It provides side-by-side research of alternative datasets to present you with unique quantitative analysis of the effects of COVID-19 and how these differ across sectors. Additionally, it offers qualitative analysis of each sector and analyzes COVID-19’s impact on leading companies. Whatever your company’s imminent strategic plans, the long-lasting impact of COVID-19 must not be overlooked. Find out how to futureproof your business operations – download our report today.
by GlobalData
Enter your details here to receive your free Report.

The new kit has been redesigned for the detection of active SARS-CoV-2 by identifying the presence of any one of eight gene targets from the virus.

It helps in providing accurate results even for current and future Covid-19 viral mutations by surveying multiple genes.

The TaqPath Covid-19 RNase P 2.0 kit, which has a turnaround time of approximately three hours, uses a newly designed assay for evaluating nasopharyngeal and nasal swab samples to detect active cases of Covid-19.

Thermo Fisher Scientific genetic testing solutions senior medical director Manoj Gandhi said: “SARS-CoV-2 is continuing to mutate, and this assay is the latest in our efforts to make sure our tests are future-proofed against those variants.

“With this product, we are offering customers the next generation of our Covid-19 diagnostic test that has inbuilt checks and balances in the face of emerging variants.”

The company stated that the new Covid-19 test kit uses an RNase P control to ensure sample quality, integrity and extraction.

It also noted that the first-generation TaqPath Covid-19 CE-IVD RT PCR Kit with a CE-IVD mark has been available in the market since March 2019.

Last month, Thermo Fisher Scientific received emergency use authorization from the US Food and Drug Administration for the TaqPath Covid-19 Fast PCR Combo Kit 2.0 and TaqPath COVID-19 RNase P Combo Kit 2.0.

The kits have been designed with increased target redundancy to address current and emerging SARS-CoV-2 variants.

Related Companies

Free Report
img

Build resilience in the face of COVID-19 disruption

COVID-19 has already affected our lives forever. The way we work, shop, eat, seek medical advice, and socialize will all be different in the future. Quite how different remains to be seen, but all industries must plan for multiple eventualities. Are you interested in actionable insights on the business challenges induced by the pandemic? GlobalData's cross-sector report analyzes the significance of this major disruptive theme across industry verticals. It provides side-by-side research of alternative datasets to present you with unique quantitative analysis of the effects of COVID-19 and how these differ across sectors. Additionally, it offers qualitative analysis of each sector and analyzes COVID-19’s impact on leading companies. Whatever your company’s imminent strategic plans, the long-lasting impact of COVID-19 must not be overlooked. Find out how to futureproof your business operations – download our report today.
by GlobalData
Enter your details here to receive your free Report.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Medical Device Network